Phage display technology for human monoclonal antibodies

Cecilia Deantonio1, Diego Cotella, Paolo Macor

  • 1Department of Health Sciences and Interdisciplinary Research Center for Autoimmune Diseases (IRCAD), University of Eastern Piedmont, Novara, Italy.

Summary

Phage display technology enables rapid in vitro selection of high-affinity antibodies. This method allows for antibody engineering to enhance affinity, specificity, and effector functions for therapeutic applications.